IN VITRO DRUG INTERACTION STUDIES OF UNI-494 INDICATE LOW RISK OF DRUG-DRUG INTERACTIONS

被引：0
|
作者：
Reddy, Guru [1 ]
Gupta, Pramod [1 ]
Khare, Atul [1 ]
Gupta, Shalabh [1 ]
机构：
[1] Unicyc Therapeut Inc, Los Altos, CA USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2023年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
27
引用
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [1] Low risk of drug-drug interactions for Ruzasvir based upon in vitro metabolism and transporter interaction studies
    Vo, Alex
    Yabut, Jocelyn
    Hafey, Michael
    Wan, Hui
    Agrawal, Nancy
    Sommadossi, Jean-Pierre
    JOURNAL OF HEPATOLOGY, 2024, 80 : S753 - S753
  • [2] Role of in vitro metabolic interactions in the conduct of drug-drug interaction (DDI) studies.
    Yuan, R
    Balian, JD
    Svadjian, R
    Uppoor, RS
    Ajayi, F
    Burnett, A
    Lesko, LJ
    Marroum, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 218 - 218
  • [3] Drug-Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies
    Zurth, Christian
    Koskinen, Mikko
    Fricke, Robert
    Prien, Olaf
    Korjamo, Timo
    Graudenz, Kristina
    Denner, Karsten
    Bairlein, Michaela
    Von Buehler, Clemens-Jeremias
    Wilkinson, Gary
    Gieschen, Hille
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2019, 44 (06) : 747 - 759
  • [4] In-vitro drug-drug interaction studies of diltiazem with floroquinolones
    Shafi, Nighat
    Siddiqui, Farhan Ahmed
    Arayne, Muhammad Saeed
    Sultana, Najma
    JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2017, 40 (20) : 1003 - 1014
  • [5] No Increased Risk of Ketoconazole Toxicity in Drug-Drug Interaction Studies
    Outeiro, Noemi
    Hohmann, Nicolas
    Mikus, Gerd
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (10): : 1203 - 1211
  • [6] Design of in vitro studies to predict in vivo inhibitory drug-drug interactions
    Benedetti, MS
    Bani, M
    PHARMACOLOGICAL RESEARCH, 1998, 38 (02) : 81 - 88
  • [7] Predicting drug-drug interactions:: In vitro veritas?
    Tucker, GT
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 23 : S13 - S13
  • [8] Risk of Drug-Drug Interactions in Out-Hospital Drug Dispensings in France: Results From the DRUG-Drug Interaction Prevalence Study
    Letinier, Louis
    Cossin, Sebastien
    Mansiaux, Yohann
    Arnaud, Mickael
    Salvo, Francesco
    Bezin, Julien
    Thiessard, Frantz
    Pariente, Antoine
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [9] The conduct of in vitro and in vivo drug-drug interaction studies: A PhRMA perspective
    Bjornsson, TD
    Callaghan, JT
    Einolf, HJ
    Fischer, V
    Gan, L
    Grimm, S
    Kao, J
    King, SP
    Miwa, G
    Ni, L
    Kumar, G
    McLeod, J
    Obach, SR
    Roberts, S
    Roe, A
    Shah, A
    Snikeris, F
    Sullivan, JT
    Tweedie, D
    Vega, JM
    Walsh, J
    Wrighton, SA
    JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (05): : 443 - 469
  • [10] A Review of CYP-Mediated Drug Interactions: Mechanisms and In Vitro Drug-Drug Interaction Assessment
    Lee, Jonghwa
    Beers, Jessica L.
    Geffert, Raeanne M.
    Jackson, Klarissa D.
    BIOMOLECULES, 2024, 14 (01)
12345